Rare Trials Summit

GeneDx is joining rare disease leaders at the Rare TrialsSummit to explore how genomic intelligence and real-world clinical data canhelp accelerate the development of therapies for rare diseases.

Visit the GeneDx exhibit table to learn how geneticallyconfirmed patient cohorts—paired with rich phenotypic and longitudinal data—cansupport more precise patient identification, stronger trial planning, and moreinformed drug development.

‍

Featured Presentation:

From Data to Discovery: Finding the Right Patients forRare Disease Trials

September 15 | 9:00–9:30 a.m.

Finding the right patients remains one of the greatestchallenges in rare disease research. This session will explore how combininggenetically confirmed cohorts with rich phenotypic and longitudinal real-worlddata can improve patient identification and help biopharma teams plan moreinformed, efficient clinical trials.

Speakers

Colleen Caleshu, MSc, LCGC
Senior Director, Translational Research, GeneDx

Sarah Chang, PhD
Medical Strategy Lead, Early Indications, UCB

Joe Walter, MBA
Senior Director of Marketing & Market Development, Neurvati Neurosciences

Connect With GeneDx

Meet with the GeneDx team in Boston to explore howgenomic and clinical intelligence can support:

·       Geneticallyconfirmed patient cohort identification

·       Trialfeasibility and site-selection strategies

·       Patient-findingand enrollment planning

·       Genotypeand phenotype characterization

·       Naturalhistory and longitudinal insights

·       Biomarkerand indication-expansion strategies

About GeneDx

GeneDx is a global leader in genomic insights, with deepexpertise in rare and inherited disease. GeneDx Infinity™ brings together oneof the world’s largest rare disease datasets with longitudinal clinicalinformation to help biopharma partners identify genetically confirmed patientpopulations, understand disease progression, and advance the development ofprecision therapies.

‍